Cover Image

Assessing SARS-CoV-2 Testing Adherence in a University Town: Recurrent Event Modeling Analysis

BackgroundHealthy Davis Together was a program launched in September 2020 in the city of Davis, California, to mitigate the spread of COVID-19 and facilitate the return to normalcy. The program involved multiple interventions, including free saliva-based asymptomatic testing, targeted communication...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yury E García (Author), Alec J Schmidt (Author), Leslie Solis (Author), María L Daza-Torres (Author), J Cricelio Montesinos-López (Author), Brad H Pollock (Author), Miriam Nuño (Author)
Format:	Book
Published:	JMIR Publications, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Wildfires and social media discourse: exploring mental health and emotional wellbeing through Twitter
by: Yury E. García, et al.
Published: (2024)

Common patterns between dengue cases, climate, and local environmental variables in Costa Rica: A wavelet approach.
by: Yury E García, et al.
Published: (2023)

Impact of social and demographic factors on the spread of the SARS-CoV-2 epidemic in the town of Nice
by: Eugènia Mariné Barjoan, et al.
Published: (2023)

The Town: Its Memorable Characters and Events
by: Hunt, Leigh, 1784-1859

Seroprevalence survey of SARS-CoV-2, community behaviors, and practices in Kansanshi and Kalumbila mining towns
by: Temple Kahilu Mumba, et al.
Published: (2023)

Recurrence of controlled mycosis fungoides after SARS-CoV-2 infection
by: Éderson Valei Lopes Oliveira, et al.
Published: (2023)

Wastewater-based SARS-CoV-2 airport surveillance: key trends at the Cape Town International Airport
by: Sizwe Nkambule, et al.
Published: (2023)

The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive
by: Hong Zhao, et al.
Published: (2021)

SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities.
by: Hannah Hussey, et al.
Published: (2024)

Identifying targets for interventions to support public adherence to government instructions to reduce transmission of SARS-CoV-2
by: Christopher J. Armitage, et al.
Published: (2021)

Logistics Workers Are a Key Factor for SARS-CoV-2 Spread in Brazilian Small Towns: Case-Control Study
by: Breno Bernardes-Souza, et al.
Published: (2021)

Reinfección por SARS-CoV-2, ¿Qué conocemos hasta el momento?
by: Karen Serrano-Arévalo, et al.
Published: (2020)

Impact of a large-scale event on SARS-CoV-2 cases and hospitalizations in the Netherlands, carnival seasons 2022 and 2023
by: Koen M.F. Gorgels, et al.
Published: (2024)

Outdoor mass gathering events and SARS-CoV-2 infection in Catalonia (North-East Spain)
by: Oren Miron, MA, et al.
Published: (2022)

Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors
by: Junichi Yoshida, et al.
Published: (2022)

Influence assessment of SARS-CoV outbreak in Riyadh on medication adherence in hypertensive patients in tertiary hospital
by: Sarah Alyousif, et al.
Published: (2023)

Severe recurrence of reactive infectious mucocutaneous eruption with extensive ocular involvement in an adult due to SARS-CoV-2
by: David Wu, PhD, et al.
Published: (2023)

Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais
by: Roberta Barros da Silva, et al.

Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
by: Edem Kojo Dzantor, et al.
Published: (2023)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

A coupled experimental and statistical approach for an assessment of SARS-CoV-2 infection risk at indoor event locations
by: Lukas Siebler, et al.
Published: (2023)

Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review
by: Martina Amanzio, et al.
Published: (2022)

Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature
by: Sara Eslait-Olaciregui, et al.
Published: (2023)

Expansion of wastewater-based disease surveillance to improve health equity in California's Central Valley: sequential shifts in case-to-wastewater and hospitalization-to-wastewater ratios
by: Krystin F. Kadonsky, et al.
Published: (2023)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)

Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event
by: Tian J, et al.
Published: (2019)

Time to Recurrent Relapses Analysis in Schizophrenic Patients by Using Recurrent Events Model
by: Leila Cheraghi, et al.
Published: (2013)

Recalcitrant verruca vulgaris regression following severe SARS-CoV-2 infection
by: Devin Barzallo, BA, et al.
Published: (2022)

SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence
by: Li Kai, et al.
Published: (2020)

Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol
by: Jeanne Goupil de Bouillé, et al.
Published: (2022)

Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on
by: Halinder S. Mangat, et al.
Published: (2022)

Features and transmission dynamics of SARS-CoV-2 superspreading events in Taiwan: Implications for effective and sustainable community-centered control
by: Yi-Ching Chen, et al.
Published: (2021)

Ivermectin: The Latin American response to SARS-CoV-2?
by: R. Rainer Echeverria, et al.
Published: (2020)

Assessing the risks of SARS-CoV-2 in wildlife
by: R. J. Delahay, et al.
Published: (2021)

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
by: Karen Y. Oróstica, et al.
Published: (2022)

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
by: Shangchen Song, et al.
Published: (2023)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

Recurrent giant cellulitis-like sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
by: Penelope Hirt, et al.
Published: (2023)

IPs-GRUAtt: An attention-based bidirectional gated recurrent unit network for predicting phosphorylation sites of SARS-CoV-2 infection
by: Guiyang Zhang, et al.
Published: (2023)

COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa
by: Bakary Sanyang, et al.
Published: (2021)